Orgenesis

Spotlight

Gilead’s Yescarta set to become England’s first routinely available personalized immunotherapy for lymphoma Finch halts biotherapeutic trial and axes 95 per cent of its staff Vertex and CRISPR Therapeutics advance towards EMA approval for exa-cel Lonza: Robust industry fundamentals are supportive of growth AGC Biologics supports commercial production of Provention Bio’s new Type 1 diabetes therapy

Follow us

Most popular News

• 1 Vertex and CRISPR Therapeutics advance towards EMA approval for exa-cel
• 2 EU spotlight on Novartis gene therapy after patient deaths
• 3 The legal view: The US biosimilars sector is maturing, and 2022 was ‘a remarkable year’ for the field
• 4 Hired and retired: New appointments in the biopharma industry
• 5 Resilience to expand global footprint, collaborating on first GMP biopharma facility in UAE

Products

View more

• Trends in Biopharmaceutical Raw Material Selection Actylis – The Partner of Choice | Watch Business Advice
• Stand-alone GMP & non-GMP Analytical Solutions for Large Molecules Catalent | Download Product Brochure
• eBook: mRNA prospects and scale-up solutions Thermo Fisher Scientific - Biosciences | Download Insight Guide
• Discover the world of upstream bioprocessing Eppendorf Bioprocess Solutions | Download Technical / White Paper

Webinars

On-demand webinars

• Bioprocessing 4.0 Webinar
• Delivery Systems for Biologics Webinar
• Cell and gene therapies: How can their promise be realized? Webinar
• Manufacture of vaccines (Part II) Webinar
• Innovations In Drug Delivery Webinar

Featured Suppliers

All

• Actylis – The Partner of Choice
• Altasciences
• Separation and Purification
• Sumitomo Chemical Europe
• Thermo Fisher Scientific - Biosciences